SARS2
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a novel coronavirus that was first identified in December 2019 in the city of Wuhan, China. It is the virus that causes the disease COVID-19, which has led to the ongoing COVID-19 pandemic.
Origin and Structure[edit]
SARS-CoV-2 is a member of the broader Coronaviridae family of viruses. It is believed to have originated in bats and jumped to humans via an intermediate host. The virus is enveloped and spherical in shape, with a core of single-stranded RNA. The virus's surface is covered in spike proteins, which it uses to enter human cells.
Transmission[edit]
SARS-CoV-2 is primarily transmitted between people through respiratory droplets and contact routes. Transmission can occur when an infected person coughs, sneezes, or talks, releasing droplets into the air that can be inhaled by people nearby. The virus can also spread if a person touches a surface or object that has the virus on it and then touches their mouth, nose, or eyes.
Symptoms and Complications[edit]
The symptoms of COVID-19 vary widely, but often include fever, cough, and difficulty breathing. Severe cases can lead to pneumonia, acute respiratory distress syndrome (ARDS), and death. Long-term complications of the disease are still being studied, but may include heart damage, lung damage, and neurological effects.
Prevention and Treatment[edit]
Prevention measures for SARS-CoV-2 include wearing masks, social distancing, and hand hygiene. Vaccines have also been developed and are being distributed globally. Treatment for COVID-19 primarily involves supportive care, though certain antiviral drugs have shown promise.
Impact[edit]
The impact of SARS-CoV-2 has been global and profound, affecting nearly every aspect of life. The virus has caused millions of deaths worldwide and has had significant economic, social, and psychological effects.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian